Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Clozapine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Recipient : Tanner Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Tanner Pharma Group Signs Versacloz Distribution Agreement with Tasman Pharma Inc.
Details : Tanner to distribute Versacloz in areas outside of the U.S where the product is not yet registered. Versacloz is indicated for the treatment of severely ill patients with schizophrenia who fail to respond to standard antipsychotic treatment.
Brand Name : Versacloz
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 22, 2020
Lead Product(s) : Clozapine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Recipient : Tanner Pharma
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?
Reset All
